Pharmaxis completes acquisition of Canadian company Topigen Pharmaceuticals Inc

9th Feb 10

Release Date: 09/02/2010 12:00am

Pharmaxis Ltd announced today it has issued 3.2 million shares on completion of the acquisition of Canadian based private biopharmaceutical company Topigen Pharmaceuticals Inc.The agreement to purchase Topigen was announced to the market on 12 January 2010.


Read full media release - pdf

Categories: News and Media